Allogene Therapeutics, Inc

Home » Allogene Therapeutics, Inc

IPO

Allogene Therapeutics, Inc

We are a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer.

Symbol

ALLO

Price Range
$16.00 - $18.00

Final Shares
1,600,000

Anticipated Date
TBD

Underwriters
Goldman Sachs & Co. LLC, J.P. Morgan, Cowen, Jefferies

To view the prospectus for Allogene Therapeutics, Inc IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253